Oncology
Revenue Yield
Stop losing revenue on complex coding audits and modifier adjustments. Partner with Apex experts trained specifically in oncology guidelines.
Common Billing Challenges in Oncology
Practicing medicine requires your full focus. Unfortunately, navigating payer-specific guidelines, bundling edits, and coding specificity often causes clinical revenue to get delayed or written off.
Documenting high-cost chemotherapy administration, hydration, and therapeutic infusions.
Accurately calculating drug wastage and reporting it with modifiers JW and JZ.
Managing complex prior authorizations for targeted biological therapies and clinical trial protocols.
Compliant Modifiers
Oncology claims require precise documentation and correct modifiers to justify reimbursement under strict NCCI guidelines.
Used to report and bill for discarded drug portions from single-dose vials.
Used to verify that zero drug wastage occurred from a single-dose vial.
Separate E/M alongside chemotherapy administration for toxic side effect evaluation.
Why General Billing Fails
- •Massive write-offs on multi-dose oncology vials due to missing -JW wastage claims
- •Incorrect sequencing of primary chemotherapy, concurrent infusion, and hydration hours
- •Failing to coordinate clinical trials codes with Medicare guidelines
- •Lack of real-time clinical authorization updates leading to immediate write-offs
Interactive Claim Pipeline
Click on each workflow phase to inspect our protocols, software rules, and certified check systems.
Infusion Prior Auth
Securing approvals for biologics, immunotherapy, and trials.
Our dedicated oncology auth team coordinates directly with payers to secure pre-approvals for high-cost drug protocols.
Phase Protocols
Frequently Asked Questions
Ready to Optimize Your Oncology Yield?
Let us conduct a complimentary review of your billing records and codes to identify hidden leaks and contract underpayments.